Abbvie Inc said on Thursday it settled all patent disputes with Novartis AG, granting it a non-exclusive license to manufacture and sell a copycat version of blockbuster drug, Humira.
from Business & Finance via Godstime David on Inoreader https://ift.tt/2ygVyVx
via
IFTTT
we need your feedback